Resverlogix published evidence of apabetalone’s beneficial effects on COVID-19
On Mar. 3, 2021, Resverlogix and QIMR Berghofer Medical Research Institute announced the publishing of an article providing…
On Mar. 3, 2021, Resverlogix and QIMR Berghofer Medical Research Institute announced the publishing of an article providing…
On Mar. 3, 2021, TGen, an affiliate of City of Hope announced that an in-depth analysis of the…
On Mar. 3, 2021, Pfizer and BioNTech, in partnership with UNICEF, announced the arrival of the first doses…
On Mar. 3, 2021, Altasciences announced support for ReAlta Life Sciences’ Phase I trial to evaluate RLS-0071 for…
On Mar. 2, 2021, the NIH announced it had launched the next version of the Accelerating Medicines Partnership…
On Mar. 2, 2021, The Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance and the WHO,…
On Mar. 2, 2021, the NIH halted a clinical trial evaluating the safety and effectiveness of COVID-19 convalescent…
On Mar. 2, 2021, Merck announced multiple agreements to support efforts to expand manufacturing capacity and supply of…
On Mar. 2, 2021, the NIH announced that it had launched a research effort to understand how SARS-CoV-2,…
On Mar. 2, 2021, the Advisory Committee on Immunization Practices (ACIP) recommended preexposure vaccination with Merck’s Ervebo was…
On Mar. 2, 2021, MediciNova announced it that given the COVID-19 vaccines currently in use and other vaccines…
On Mar. 2, 2021, NanoViricides reported that NV-CoV-2 and NV-CoV-2-R were found to be highly effective in comparison…
On Mar. 2, 2021, Innovation Pharmaceuticals reported that eight sites were participating in the Companyï¾’s international Phase 2…
On Mar. 2, 2021, Cerecor announced final efficacy data including 60-day mortality from their completed US-based, multi-center (10…
On Mar. 2, 2021, the Biden Administration has helped forge a historic manufacturing collaboration between two of the…
On Mar. 1, 2021, the WHO announced that the first COVID-19 vaccination campaigns in Africa using COVAX doses…
On Mar. 1, 2021, Colombia became the first country in the Americas to receive COVID-19 vaccines through the…
On Mar. 1, 2021, Quidel announced that it had received an Emergency Use Authorization (EUA) from the FDA,…
On Mar. 1, 2021, a study from Washington University School of Medicine in St. Louis provided evidence that…
On Feb. 28, 2021, after a transparent evidence-based review of all available data, the Advisory Committee on Immunization…
On Feb. 28, 2021, Johnson & Johnson announced that the U.S. Centers for Disease Control and Preventionï¾’s (CDC)…
On Feb. 27, 2021, Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) had issued…
On Feb. 26, 2021, Roche announced it had been granted special approval by the German Federal Institute for…
On Feb. 26, 2021, Innovation Pharmaceuticals announced that after an interim review, by an independent Data Monitoring Committee…
On Feb. 26, 2021, Novavax and Takeda Pharmaceutical announced an exclusive license agreement for Takeda’s development, manufacturing and…
On Feb. 26, 2021, Johnson & Johnson announced that the FDA Vaccines and Related Biological Products Advisory Committee…
On Feb. 26, 2021, Pfizer announced that the European Medicines Agency (EMA) accepted for review the Marketing Authorization…
On Feb. 26, 2021, Regeneron announced the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use…
On Feb. 25, 2021, the FDA granted approval to Sarepta Therapeutics for Amondys 45 (casimersen) injection for the…
On Feb. 25, 2021, the U.S. Food and Drug Administration announced that it was allowing undiluted frozen vials…